3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2-cyclopenten-1-one → N-[6-(3-oxocyclopenten-1-yl)pyridazin-3-yl]-2-pyridin-2-ylacetamide
Reaction equation
CC1(C(C)(C)OB([C:1]([CH2:6][CH2:5][C:3]2=[O:4])=[CH:2]2)O1)C.Br[c:7]1[n:22][n:21][c:10]([NH:11][C:12]([CH2:14][c:15]2[n:20][cH:19][cH:18][cH:17][cH:16]2)=[O:13])[cH:9][cH:8]1>>[O:13]=[C:12]([NH:11][c:10]1[n:21][n:22][c:7]([C:1]([CH2:6][CH2:5][C:3]2=[O:4])=[CH:2]2)[cH:8][cH:9]1)[CH2:14][c:15]3[n:20][cH:19][cH:18][cH:17][cH:16]3Participants
7
Reactant 2
Product 1
Reagents, catalysts & solvents 4
Conditions
- Temperature
- 80 °C
Sources & evidence
- ORD record
- ord-a47deb4c9fa348ae8e99a97063bd2f2e
- Source dataset
- 39k HTE dataset from Pfizer
- Original link
- View source
Reaction notes
Loading…